<?xml version="1.0" encoding="UTF-8"?>
<p id="Par81">Epstein–Barr virus (EBV), a herpesvirus, is an oncogenic virus first isolated and identified from a Burkitt’s lymphoma patient in 1964 [
 <xref ref-type="bibr" rid="CR77">77</xref>]. As one of the most common human viruses, EBV causes infectious mononucleosis and is associated with specific forms of lymphoma. There are about 200,000 cases of cancer associated with this virus, with about 140,000 deaths reported annually [
 <xref ref-type="bibr" rid="CR78">78</xref>]. Common antiviral therapies can suppress the replication of active-viruses. However, the existing vaccines or drugs are not effective in eradicating the latent infection of EBV.
</p>
